Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma
The study aims to investigate potential diagnostic and prognostic value of immunohistochemical expression of Nestin, a progenitor cell marker, in a large series of 1,050 primary liver cancer samples collected from multiple institutes across the US, Europe and Asia.
The research utilised Crosscope’s cloud-based software for pathology reviews of digital slides. The representative slides can be available here.
Read the full paper here.
Sign up for our newsletter
Receive general news, updates and latest development on AI